JXFG.F Stock Overview

An investment holding company, provides assisted reproductive services (ARS) in China and the United States. More details

JXFG.F fundamental analysis
Snowflake Score
Valuation	3/6
Future Growth	3/6
Past Performance	4/6
Financial Health	3/6
Dividends	3/6

Rewards

Trading at 64.5% below our estimate of its fair value

Earnings are forecast to grow 19.63% per year

Earnings grew by 101.1% over the past year

Risk Analysis

Shares are highly illiquid

Unstable dividend track record

My Notes

Capture your thoughts, links and company narrative

Jinxin Fertility Group Limited Competitors

Pennant Group

NasdaqGS:PNTG

US$940.5m

Astrana Health

NasdaqCM:ASTH

US$1.7b

AMN Healthcare Services

NYSE:AMN

US$873.4m

Castle Biosciences

NasdaqGM:CSTL

US$771.0m

Price History & Performance

Summary of share price highs, lows and changes for Jinxin Fertility Group
Historical stock prices
Current Share Price	HK$0.28
52 Week High	HK$0.50
52 Week Low	HK$0.20
Beta	1.4
1 Month Change	n/a
3 Month Change	n/a
1 Year Change	n/a
3 Year Change	n/a
5 Year Change	n/a
Change since IPO	-89.37%

Recent updates

Shareholder Returns

	JXFG.F	US Healthcare	US Market
7D	-42.9%	-1.0%	-2.7%
1Y	n/a	-10.2%	23.4%

Return vs Industry: Insufficient data to determine how JXFG.F performed against the US Healthcare industry.

Return vs Market: Insufficient data to determine how JXFG.F performed against the US Market.

Price Volatility

Is JXFG.F's price volatile compared to industry and market?
JXFG.F volatility
JXFG.F Average Weekly Movement	n/a
Healthcare Industry Average Movement	7.6%
Market Average Movement	6.3%
10% most volatile stocks in US Market	16.9%
10% least volatile stocks in US Market	3.2%

Stable Share Price: JXFG.F's share price has been volatile over the past 3 months compared to the US market.

Volatility Over Time: Insufficient data to determine JXFG.F's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
1951	3,779	Yang Dong	www.jxr-fertility.com

Jinxin Fertility Group Limited, an investment holding company, provides assisted reproductive services (ARS) in China and the United States. The company primarily offers two treatment solutions, including artificial insemination that is performed with either husband’s sperm or a donor sperm; and IVF technology, whereby fertilization is achieved through conventional in vitro fertilization and embryo transfer or IVF with intracytoplasmic sperm injection. It also provides related services, such as nutrition guidance, Chinese medicine treatment, and psychological counseling to support the ARS.

Jinxin Fertility Group Limited Fundamentals Summary

How do Jinxin Fertility Group's earnings and revenue compare to its market cap?
JXFG.F fundamental statistics
Market cap	US$991.90m
Earnings (TTM)	US$42.60m
Revenue (TTM)	US$397.30m

23.3x

P/E Ratio

2.5x

P/S Ratio

Is JXFG.F overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
JXFG.F income statement (TTM)
Revenue	CN¥2.90b
Cost of Revenue	CN¥1.70b
Gross Profit	CN¥1.19b
Other Expenses	CN¥883.30m
Earnings	CN¥310.84m

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)	0.11
Gross Margin	41.19%
Net Profit Margin	10.72%
Debt/Equity Ratio	20.9%

How did JXFG.F perform over the long term?

See historical performance and comparison

Dividends

2.0%

Current Dividend Yield

47%

Payout Ratio

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/12/23 10:11
End of Day Share Price	2024/12/19 00:00
Earnings	2024/06/30
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Jinxin Fertility Group Limited is covered by 30 analysts. 16 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Sharon Shi	BOCI Research Ltd.
Ethan Cui	BofA Global Research
Qianyi Li	China International Capital Corporation Limited